Coherus BioSciences Inc (CHRS)
1.51
-0.06
(-3.82%)
USD |
NASDAQ |
Jan 08, 16:00
1.50
-0.01
(-0.66%)
Pre-Market: 08:09
Coherus BioSciences Profit Margin (Quarterly): -15.19% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 33.28% |
| Eli Lilly and Co | 8.48% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -10.57K% |
| IGC Pharma Inc | -416.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -0.07% |
| Return on Invested Capital | -0.16% |
| Gross Profit Margin (Quarterly) | 70.69% |
| Operating Margin (Quarterly) | -9.02% |
| Return on Net Operating Assets | -0.12% |